Navar presented the results of the phase 3 CORALreef Lipids trial, evaluating the oral PCSK9 inhibitor enlicitide in adult ...
Sotatercept (Winrevair; Merck) is enhancing treatment for patients with pulmonary arterial hypertension (PAH), explained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback